Therapeutic angiogenesis of PLGA-heparin nanoparticle in mouse ischemic limb

Journal of Nanomaterials

Volumn 2012, Issue , 2012, Pages

  Lian, Lishan ^a   Tang, Feng ^a   Yang, Jing ^a   Liu, Changwei ^a   Li, Yongjun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENTS; AVERAGE DIAMETER; BIOLOGICAL EFFECTS; CAPILLARY DENSITY; DELIVERY SYSTEMS; EXPRESSION LEVELS; GROWTH FACTOR; IN-CONTROL; IN-VITRO; ISCHEMIC LIMBS; LOADING EFFICIENCY; RELEASE TIME; THERAPEUTIC ANGIOGENESIS;

MAMMALS; NANOPARTICLES; SURFACE MORPHOLOGY;

POLYSACCHARIDES;

EID: 84863708524     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2012/193704     Document Type: Article

References (26)

1. He Y., Jiang Y., Wang J., Fan L., Li X., Hu F. B., Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China Journal of Vascular Surgery 2006 44 2 333 338 (Pubitemid 44142914)
2. Kusumanto Y. H., Van Weel V., Mulder N. H., Smit A. J., Van Den Dungen J. J. A. M., Hooymans J. M. M., Sluiter W. J., Tio R. A., Quax P. H. A., Gans R. O. B., Dullaart R. P. F., Hospers G. A. P., Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial Human Gene Therapy 2006 17 6 683 691 (Pubitemid 43970708)
3. Cristofaro B., Stone O. A., Caporali A., Dawbarn D., Ieronimakis N., Reyes M., Madeddu P., Bates D. O., Emanueli C., Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 6 1143 1150
4. Zhou H., Yang Y. H., Binmadi N. O., The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma. Experimental Cell Research. In press
5. Sobel M., Verhaeghe R., Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 2008 133 6 815S 843S (Pubitemid 351892977)
6. Kearon C., Kahn S. R., Agnelli G., Goldhaber S., Raskob G. E., Comerota A. J., Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 2008 133 6 454S 545S (Pubitemid 351892971)
7. Norgren L., Hiatt W. R., Dormandy J. A., Nehler M. R., Harris K. A., Fowkes F. G. R., Inter-Society consensus for the management of peripheral arterial disease (TASC II) European Journal of Vascular and Endovascular Surgery 2007 33 S32 S53
8. Lane D. A., Lane D. A., Lindahl U., Heparin binding and neutralizing protein Heparin: Chemical and Biological Properties, Clinical Applications 1989 Boca Raton, Fla, USA CRC Press 363 391
9. Rosenberg R. D., Lam L., Correlation between structure and function of heparin Proceedings of the National Academy of Sciences of the United States of America 1979 76 3 1218 1222 (Pubitemid 9135185)
10. Hirsh J., Warkentin T. E., Shaugnessy S. G., Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety Chest 2001 119 supplement 64S 94S
11. Stern M., Ulrich K., Geddes D. M., Alton E. W. F. W., Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo Gene Therapy 2003 10 16 1282 1288 (Pubitemid 36987118)
12. Kang S. W., Lim H. W., Seo S. W., Jeon O., Lee M., Kim B. S., Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs Biomaterials 2008 29 8 1109 1117 (Pubitemid 350296314)
13. Jeon O., Kang S. W., Lim H. W., Hyung Chung J., Kim B. S., Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel Biomaterials 2006 27 8 1598 1607 (Pubitemid 41739585)
14. Yang J., Song C., Li Y., Polymeric Particles with therapeutic gene for gene therapy: preparation and in vivo gene transfer study BioMedical Engineering 2005 22 3 438 442
15. Lemmouchi Y., Schacht E., Kageruka P., De Deken R., Diarra B., Diall O., Geerts S., Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies Biomaterials 1998 19 20 1827 1837 (Pubitemid 28519964)
16. Jain R. A., The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 2000 21 23 2475 2490
17. Liu X., Yang J., Zhou C., Constructing hybrid films of conjugated oligomers and gold nanoparticles for efficient photoeletronic properties Physical Chemistry Chemical Physics 2011 13 6 1984 1989
18. Lamprecht A., Ubrich N., Hombreiro Pérez M., Lehr C. M., Hoffman M., Maincent P., Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification International Journal of Pharmaceutics 1999 184 1 97 105 (Pubitemid 29308999)
19. Couffinhal T., Silver M., Zheng L. P., Kearney M., Witzenbichler B., Isner J. M., Mouse model of angiogenesis American Journal of Pathology 1998 152 6 1667 1679 (Pubitemid 28275025)
20. Kalaria D. R., Sharma G., Beniwal V., Ravi Kumar M. N. V., Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats Pharmaceutical Research 2009 26 3 492 501
21. Sameni J., Bukhari N. I., Azlan N. A., Julianto T., Majeed A. B. A., The effect of preparation parameters on the size and morphology of PLGA-based nanoparticles Proceedings of the IEEE Symposium on Industrial Electronics and Applications (ISIEA '09) October 2009 Kuala Lumpur, Malaysia 700 704
22. Lv J., Zhao Y., Li G., Li Y., Liu H., Li Y., Zhu D., Wang S., Aggregation-enhanced emission in gold nanoparticles protected by tetradentate perylene derivative Langmuir 2009 25 19 11351 11357
23. Rissanen T. T., Vajanto I., Hiltunen M. O., Rutanen J., Kettunen M. I., Niemi M., Leppnen P., Turunen M. P., Markkanen J. E., Arve K., Alhava E., Kauppinen R. A., Yl-Herttuala S., Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Fik-1) in ischemic skeletal muscle and its regeneration American Journal of Pathology 2002 160 4 1393 1403 (Pubitemid 34411643)
24. Zarnegar R., Michalopoulos G. K., The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis Journal of Cell Biology 1995 129 5 1177 1180
25. Madonna R., Cevik C., Nasser M., Hepatocyte growth factor: molecular biomarker and player in cardioprotection and cardiovascular regeneration Thrombosis and Haemostasis 2012 107 4 656 661
26. Morishita R., Makino H., Aoki M., Hashiya N., Yamasaki K., Azuma J., Taniyama Y., Sawa Y., Kaneda Y., Ogihara T., Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 3 713 720